A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience
Issue link: http://innovationscns.epubxp.com/i/796206
Innovations in CLINICAL NEUROSCIENCE [ V O L U M E 1 4 , N U M B E R 1 – 2 , J A N U A R Y – F E B R U A R Y 2 0 1 7 ] 38 detection of mild Alzheimer's disease and mild cognitive impairment without dementia. J Int Neuropsychol Soc. 2004;10:91–100. 16. Snitz B, Loewensetin DA, Saxton K, Ganguli M. A novel approach to assessing memory at the population level: vulnerability to semantic interference. Int Psychogeriatrics. 2010;1:1–10. 17. Buschke H, Silwinski M, Kuslansky G, Lipton RB. Aging, encoding specificity, and memory change in the Double Memory Test. J Int Neuropsychol Soc. 1995;5:483–493. 18. Buschke H, Silwinski MJ, Kuslanski G, Lipton RB. Diagnosis of early dementia by the double memory test. Neurology. 1997;48:989–996. 19. Salmon DP, Bondi MW. Neuropsychological assessment of dementia. Ann Rev Psychol. 2009;60:257- 20. Thompson C, Henry JD, Rendell PG, et al. Prospective memory function in mild cognitive impairment and early dementia. J Int Neuropsychol Soc. 2010;16:318–325. 21. Spındola L, Brucki SMD. Prospective memory in Alzheimer's disease and mild cognitive impairment. Dement Neuropsychol. 2011;5:64–68. 22. Hernandez-Cardenache R, Burguera L, Acevedo A, et al. Evaluating different aspects of prospective memory in amnestic and nonamnestic mild cognitive impairment. ISRN Neurol. 2014:805929. 23. Cavedo E, Lista S, Khachaturian Z, et al. The road ahead to cure Alzheimer's disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations. J Prev Alzheimers Dis. 2014;1(3):181–202. 24. Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement. 2011;7:270–279. 25. Curiel R, Crocco E, Acevedo A, et al. A new scale for the evaluation of proactive and retroactive interference in mild cognitive impairment and early Alzheimer's disease. J Aging Sci. 2014.1: http://dx.doi.org/10.4172/2329- 8847.1000102 26. Crocco E, Curiel R, Acevedo A, et al. An evaluation of deficits in semantic cueing and proactive and retroactive interference as early features of Alzheimer's disease. Am J Geriatric Psychiat. 2014;22:889–897. 27. Loewenstein DA, Curiel RE, Greig-Custo MT, et al. The Relationship between a novel test of semantic interference (LASSI-L) and global and regional accumulation of amyloid in the brains of community-dwelling elders. Presented at Alzheimer's Association Annual Conference. Washington, DC: 18–23 July 2015. 28. Parra MA, Abrahams S, Logie RH, et al. Visual short-term memory binding deficits in familial Alzheimer's disease. Brain. 2010;133:2702–2713. 29. Parra MA, Sala SD, Abrahams S, et al. Specific deficit of colour-colour short- term memory binding in sporadic and familial Alzheimer's disease. Neuropsychologia. 2011;49:1943–1952. 30. Della Sala S, Parra MA, Fabi K, et al. Short-term memory binding is impaired in AD but not in non-AD dementias. Neuropsychologia. 2012;50:833–840. 31. Rentz DM, Parra Rodriguez MA, Amariglio R, et al. Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimers Res Ther. 2013;5:58–68. 31. Marshall GA, Amariglio RE, Sperling RA, Rentz DM. Activities of daily living: Where do they fit in the diagnosis of Alzheimer's disease? Neurodegener Dis Manag. 2012;2:483–491. 33. Farias ST, Chou E, Harvey DJ, et al. Longitudinal trajectories of everyday function by diagnostic status. Psychol Aging. 2013;28:1070–1075. 34. Marson D. Investigating functional impairment in preclinical Alzheimer's disease: potential measure characteristics and methodology. J Prevention Alzheimer's Disease. 2015;2:4–6. 35. Griffith HR, Belue K, Sicola A, et al. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology. 2003;60:449–457. 36. Triebel K, Martin R, Griffith HR, et al. Declining financial capacity in mild cognitive impairment: a one-year longitudinal study. Neurology. 2009;73:928–934. 37. Jefferson AL, Byerly LK, Vanderhill S, et al. Characterization of activities of daily living in individuals with mild cognitive impairment. Am J Geriatr Psychiat. 2008;16:375–383. 38. Tomaszewski Farias S, Mungas D, et al. MCI is associated with deficits in everyday functioning. Alzheim Dis Assoc Disord. 2006;20:217–223. 39. Marson DC, Sawrie SM, Snyder S, et al. Assessing financial capacity in patients with Alzheimer disease: a conceptual model and prototype instrument. Arch Neurol. 2000;57:877–884. 40. Marson DC, Triebel KL, Gerstenecker A, et al. Detecting declining financial skills in preclinical Alzheimer's disease: the Financial Capacity Instrument--Short Form. Presented at the 10th Annual Autumn Conference of the International Society for CNS Clinical Trials and Methodology (ISCTM). Boston, MA: 6–8 October 2014. 41. Marson D, Triebel K, Gerstenecker A, et al. Detecting declining functional skills in preclinical Alzheimer's disease: the Financial Capacity Instrument—short form. J Prevent Alzheim Dis. 2014;1:265. 42. Widera E, Steenpass V, Marson D, Sudore R. Finances in the older patient with cognitive impairment: "He didn't want me to take over." JAMA. 2011;305(7):698–706. 43. Patterson TL, Goldman S, McKibbin CL, et al. UCSD performance-based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27:235–245. 44. Goldberg TE, Koppel J, Keehlisen L, et al. Performance-based measures of everyday function in mild cognitive impairment. Am J Psychiat. 2010;167:845–845. 45. Gomar JJ, Harvey PD, Bobes-Bascaran MT, et al. Development and cross- validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry.